Kissei Pharmaceutical , Ltd. Total Liabilities

The latest total liabilities for KSPHF is $40B as of June 2026. That compares with $35B in the prior-year period — up 11.5% year over year. Investors often review this figure alongside Kissei Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, KSPHF's total liabilities moved from $35B to $40B — a 11.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kissei Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A total liabilities figure of $40B for KSPHF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KSPHF's total liabilities ($40B), review year-over-year change from $35B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.